Evaluation of thiol/disulfide hemostasis and serum Ischemia modified albumin as oxidative stress biomarkers in systemic lupus erythematosus patients: Relationship with major organ involvement and disease activity.

Selime ErmuratElif Güler KazanciDilara Isiyel TokaKoray AyarFunda Karakoyunlu ErenSalim Neşelioğlu

Published in: Lupus (2022)

It is thought that thiol/disulfide hemostasis and IMA levels may be used as ideal biomarkers of OS in SLE patients and may reflect the disease activity and major organ involvement.

Keyphrases

disease activity
systemic lupus erythematosus
rheumatoid arthritis
end stage renal disease
oxidative stress
rheumatoid arthritis patients
ankylosing spondylitis
ejection fraction
chronic kidney disease
newly diagnosed
juvenile idiopathic arthritis
dna damage
patient reported outcomes
ischemia reperfusion injury